NASDAQ:ANPC
Delisted
AnPac Bio-Medical Science Co., Ltd. Stock News
$4.37
+0 (+0%)
At Close: Aug 18, 2023
AnPac Bio Reports Strong First Quarter in 2021, with 137.2% Increase in Revenue and Record Number of Commercial Tests Completed
06:30am, Thursday, 27'th May 2021
PHILADELPHIA, May 27, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and
AnPac Bio Shares Jump on Cancer Treatment Technology Related Joint Venture
08:15am, Tuesday, 25'th May 2021
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) will establish a joint venture with its founder and chairman, Dr. Chris Chang Yu, and certain other individuals to develop a new cancer treatment techn
ANPC Stock Price: Over 6% Increase Pre-Market Explanation
06:57am, Tuesday, 25'th May 2021
The stock price of AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) increased by over 6% pre-market. This is why it happened.
SAN JOSE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (ANPC) (“AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the
AnPac Bio-Medical Science Co., Ltd. (ANPC) CEO Dr. Chris Yu on Q4 2020 Results - Earnings Call Transcript
01:01pm, Saturday, 01'st May 2021
AnPac Bio-Medical Science Co., Ltd. (ANPC) CEO Dr. Chris Yu on Q4 2020 Results - Earnings Call Transcript
AnPac Bio Announces Filing of Annual Report on Form 20-F for 2020
04:45pm, Friday, 30'th Apr 2021
SAN JOSE, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in China and the
AnPac Bio to Report Fiscal Year 2020 Financial Results on Friday, April 30, 2021
05:03pm, Tuesday, 27'th Apr 2021
Earnings Call Scheduled for 8:30 am ET on April 30, 2021 Earnings Call Scheduled for 8:30 am ET on April 30, 2021
AnPac Bio Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021, Increasing Approximately 130% Compared to Q1, 2020
04:15pm, Friday, 16'th Apr 2021
SAN JOSE, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in Chi
ANPC Stock Price Increased 49.22%: Why It Happened
09:02am, Wednesday, 10'th Mar 2021
The stock price of AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) increased by 49.22% yesterday. These are the details.
ANPC Stock Price Increases Over 60% Pre-Market: Why It Happened
08:11am, Tuesday, 09'th Mar 2021
The stock price of AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) has increased by over 60% pre-market. This is why it happened.
AnPac Bio Developed and Completed Evaluations of New Generation Cancer Detection Sensor with Improved Performance
07:30am, Tuesday, 09'th Mar 2021
SAN JOSE, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and
AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement
04:35pm, Friday, 05'th Mar 2021
SAN JOSE, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and t
SAN JOSE, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and th
AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection
07:30am, Monday, 01'st Feb 2021
Continues to Innovate and Build Strong IP Portfolio Continues to Innovate and Build Strong IP Portfolio
5 Biopharma Stocks Making Big Moves Monday
11:33am, Monday, 14'th Dec 2020
Even as the broader market trades higher in reaction to the availability of the first coronavirus vaccine under emergency use authorization, a slew of biopharma stocks are moving on company-specific u
